Literature DB >> 27279615

RNA Binding of Ebola Virus VP30 Is Essential for Activating Viral Transcription.

Nadine Biedenkopf1, Julia Schlereth2, Arnold Grünweller2, Stephan Becker3, Roland K Hartmann4.   

Abstract

UNLABELLED: The template for Ebola virus (EBOV) transcription and replication is the helical viral nucleocapsid composed of the viral negative-sense (-) RNA genome, which is complexed by the nucleoprotein (NP), VP35, polymerase L, VP24, and VP30. While viral replication is exerted by polymerase L and its cofactor VP35, EBOV mRNA synthesis is regulated by the viral nucleocapsid protein VP30, an essential EBOV-specific transcription factor. VP30 is a homohexameric phosphoprotein containing a nonconventional zinc finger. The transcriptional support activity of VP30 is strongly influenced by its phosphorylation state. We studied here how RNA binding contributed to VP30's function in transcriptional activation. Using a novel mobility shift assay and the 3'-terminal 154 nucleotides of the EBOV genome as a standard RNA substrate, we detected that RNA binding of VP30 was severely impaired by VP30 mutations that (i) destroy the protein's capability to form homohexamers, (ii) disrupt the integrity of its zinc finger domain, (iii) mimic its fully phosphorylated state, or (iv) alter the putative RNA binding region. RNA binding of the mutant VP30 proteins correlated strongly with their transcriptional support activity. Furthermore, we showed that the interaction between VP30 and the polymerase cofactor VP35 is RNA dependent, while formation of VP30 homohexamers and VP35 homotetramers is not. Our data indicate that RNA binding of VP30 is essential for its transcriptional support activity and stabilizes complexes of VP35/L polymerase with the (-) RNA template to favor productive transcriptional initiation in the presence of termination-active RNA secondary structures. IMPORTANCE: Ebola virus causes severe fevers with unusually high case fatality rates. The recent outbreak of Ebola virus in West Africa claimed more than 11,000 lives and threatened to destabilize a whole region because of its dramatic effects on the public health systems. It is currently not completely understood how Ebola virus manages to balance viral transcription and replication in the infected cells. This study shows that transcriptional support activity of the Ebola virus transcription factor VP30 is highly correlated with its ability to bind viral RNA. The interaction between VP30 and VP35, the Ebola virus polymerase cofactor, is dependent on the presence of RNA as well. Our data contribute to the understanding of the dynamic interplay between nucleocapsid proteins and the viral RNA template in order to promote viral RNA synthesis.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27279615      PMCID: PMC4984652          DOI: 10.1128/JVI.00271-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Structural dissection of Ebola virus and its assembly determinants using cryo-electron tomography.

Authors:  Tanmay A M Bharat; Takeshi Noda; James D Riches; Verena Kraehling; Larissa Kolesnikova; Stephan Becker; Yoshihiro Kawaoka; John A G Briggs
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-27       Impact factor: 11.205

2.  Multivesicular bodies as a platform for formation of the Marburg virus envelope.

Authors:  Larissa Kolesnikova; Beate Berghöfer; Sandra Bamberg; Stephan Becker
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

3.  Infection of naive target cells with virus-like particles: implications for the function of ebola virus VP24.

Authors:  Thomas Hoenen; Allison Groseth; Larissa Kolesnikova; Steven Theriault; Hideki Ebihara; Bettina Hartlieb; Sandra Bamberg; Heinz Feldmann; Ute Ströher; Stephan Becker
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

4.  Homo-oligomerization facilitates the interferon-antagonist activity of the ebolavirus VP35 protein.

Authors:  St Patrick Reid; Washington B Cárdenas; Christopher F Basler
Journal:  Virology       Date:  2005-08-10       Impact factor: 3.616

Review 5.  Progress in filovirus vaccine development: evaluating the potential for clinical use.

Authors:  Darryl Falzarano; Thomas W Geisbert; Heinz Feldmann
Journal:  Expert Rev Vaccines       Date:  2011-01       Impact factor: 5.217

6.  The respiratory syncytial virus M2-1 protein forms tetramers and interacts with RNA and P in a competitive manner.

Authors:  Thi-Lan Tran; Nathalie Castagné; Virginie Dubosclard; Sylvie Noinville; Emmanuelle Koch; Mohammed Moudjou; Céline Henry; Julie Bernard; Robert Paul Yeo; Jean-François Eléouët
Journal:  J Virol       Date:  2009-04-22       Impact factor: 5.103

7.  Ebola virus VP30 is an RNA binding protein.

Authors:  Sinu P John; Tan Wang; Scott Steffen; Sonia Longhi; Connie S Schmaljohn; Colleen B Jonsson
Journal:  J Virol       Date:  2007-06-13       Impact factor: 5.103

8.  Phosphorylation of VP30 impairs ebola virus transcription.

Authors:  Jens Modrof; Elke Mühlberger; Hans-Dieter Klenk; Stephan Becker
Journal:  J Biol Chem       Date:  2002-06-06       Impact factor: 5.157

9.  West African Ebola epidemic after one year--slowing but not yet under control.

Authors:  Junerlyn Agua-Agum; Archchun Ariyarajah; Bruce Aylward; Isobel M Blake; Richard Brennan; Anne Cori; Christl A Donnelly; Ilaria Dorigatti; Christopher Dye; Tim Eckmanns; Neil M Ferguson; Pierre Formenty; Christophe Fraser; Erika Garcia; Tini Garske; Wes Hinsley; David Holmes; Stéphane Hugonnet; Swathi Iyengar; Thibaut Jombart; Ravi Krishnan; Sascha Meijers; Harriet L Mills; Yasmine Mohamed; Gemma Nedjati-Gilani; Emily Newton; Pierre Nouvellet; Louise Pelletier; Devin Perkins; Steven Riley; Maria Sagrado; Johannes Schnitzler; Dirk Schumacher; Anita Shah; Maria D Van Kerkhove; Olivia Varsaneux; Niluka Wijekoon Kannangarage
Journal:  N Engl J Med       Date:  2014-12-24       Impact factor: 91.245

Review 10.  Lsm proteins and Hfq: Life at the 3' end.

Authors:  Carol J Wilusz; Jeffrey Wilusz
Journal:  RNA Biol       Date:  2013-02-07       Impact factor: 4.652

View more
  20 in total

1.  Regulation of VP30-Dependent Transcription by RNA Sequence and Structure in the Genomic Ebola Virus Promoter.

Authors:  Simone Bach; Jana-Christin Demper; Arnold Grünweller; Stephan Becker; Nadine Biedenkopf; Roland K Hartmann
Journal:  J Virol       Date:  2020-12-02       Impact factor: 5.103

2.  RNA secondary structure at the transcription start site influences EBOV transcription initiation and replication in a length- and stability-dependent manner.

Authors:  Simone Bach; Jana-Christin Demper; Nadine Biedenkopf; Stephan Becker; Roland K Hartmann
Journal:  RNA Biol       Date:  2020-10-22       Impact factor: 4.652

3.  TRIM25 and ZAP target the Ebola virus ribonucleoprotein complex to mediate interferon-induced restriction.

Authors:  Rui Pedro Galão; Harry Wilson; Kristina L Schierhorn; Franka Debeljak; Bianca S Bodmer; Daniel Goldhill; Thomas Hoenen; Sam J Wilson; Chad M Swanson; Stuart J D Neil
Journal:  PLoS Pathog       Date:  2022-05-09       Impact factor: 6.823

4.  Role of VP30 Phosphorylation in Ebola Virus Nucleocapsid Assembly and Transport.

Authors:  Yuki Takamatsu; Tomoki Yoshikawa; Takeshi Kurosu; Shuetsu Fukushi; Noriyo Nagata; Masayuki Shimojima; Hideki Ebihara; Masayuki Saijo; Takeshi Noda
Journal:  J Virol       Date:  2022-08-22       Impact factor: 6.549

5.  Protein Phosphatase 1α Interacts with Venezuelan Equine Encephalitis Virus Capsid Protein and Regulates Viral Replication through Modulation of Capsid Phosphorylation.

Authors:  Brian D Carey; Tatiana Ammosova; Chelsea Pinkham; Xionghao Lin; Weidong Zhou; Lance A Liotta; Sergei Nekhai; Kylene Kehn-Hall
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

6.  Ebola virus proteins NP, VP35, and VP24 are essential and sufficient to mediate nucleocapsid transport.

Authors:  Yuki Takamatsu; Larissa Kolesnikova; Stephan Becker
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-16       Impact factor: 11.205

7.  The Host E3-Ubiquitin Ligase TRIM6 Ubiquitinates the Ebola Virus VP35 Protein and Promotes Virus Replication.

Authors:  Preeti Bharaj; Colm Atkins; Priya Luthra; Maria Isabel Giraldo; Brian E Dawes; Lisa Miorin; Jeffrey R Johnson; Nevan J Krogan; Christopher F Basler; Alexander N Freiberg; Ricardo Rajsbaum
Journal:  J Virol       Date:  2017-08-24       Impact factor: 5.103

8.  RNA binding specificity of Ebola virus transcription factor VP30.

Authors:  Julia Schlereth; Arnold Grünweller; Nadine Biedenkopf; Stephan Becker; Roland K Hartmann
Journal:  RNA Biol       Date:  2016-06-17       Impact factor: 4.652

Review 9.  Distinct Genome Replication and Transcription Strategies within the Growing Filovirus Family.

Authors:  Adam J Hume; Elke Mühlberger
Journal:  J Mol Biol       Date:  2019-06-29       Impact factor: 5.469

10.  Phosphorylated VP30 of Marburg Virus Is a Repressor of Transcription

Authors:  Bersabeh Tigabu; Palaniappan Ramanathan; Andrey Ivanov; Xionghao Lin; Philipp A Ilinykh; Christian S Parry; Alexander N Freiberg; Sergei Nekhai; Alexander Bukreyev
Journal:  J Virol       Date:  2018-10-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.